Logo image of TKNO

ALPHA TEKNOVA INC (TKNO) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:TKNO - US02080L1026 - Common Stock

3.8 USD
-0.01 (-0.26%)
Last: 12/31/2025, 8:00:01 PM

TKNO Key Statistics, Chart & Performance

Key Statistics
Market Cap203.41M
Revenue(TTM)39.80M
Net Income(TTM)-18.22M
Shares53.53M
Float10.08M
52 Week High10.37
52 Week Low3.6
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.35
PEN/A
Fwd PEN/A
Earnings (Next)02-25 2026-02-25/amc
IPO2021-06-25
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


TKNO short term performance overview.The bars show the price performance of TKNO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

TKNO long term performance overview.The bars show the price performance of TKNO in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -10 -20 -30 -40 -50

The current stock price of TKNO is 3.8 USD. In the past month the price decreased by -14.03%. In the past year, price decreased by -56.37%.

ALPHA TEKNOVA INC / TKNO Daily stock chart

TKNO Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 25.87 217.71B
DHR DANAHER CORP 29.69 161.70B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 183 55.61B
A AGILENT TECHNOLOGIES INC 24.39 38.58B
IQV IQVIA HOLDINGS INC 19.38 38.39B
MTD METTLER-TOLEDO INTERNATIONAL 33.32 28.48B
WAT WATERS CORP 29.91 22.61B
ILMN ILLUMINA INC 30.08 20.04B
WST WEST PHARMACEUTICAL SERVICES 38.92 19.79B
MEDP MEDPACE HOLDINGS INC 39.28 15.82B
RVTY REVVITY INC 20.2 10.97B
TEM TEMPUS AI INC N/A 10.51B

About TKNO

Company Profile

TKNO logo image Alpha Teknova, Inc. engages in the manufacture of cell culture media and supplements. The company is headquartered in Hollister, California and currently employs 173 full-time employees. The company went IPO on 2021-06-25. The company offers two primary product categories, which include lab essentials and clinical solutions. The company also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The firm offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. The company supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.

Company Info

ALPHA TEKNOVA INC

2451 Bert Drive

Hollister CALIFORNIA US

CEO: Stephen Gunstream

Employees: 173

TKNO Company Website

TKNO Investor Relations

Phone: 18316371100

ALPHA TEKNOVA INC / TKNO FAQ

Can you describe the business of ALPHA TEKNOVA INC?

Alpha Teknova, Inc. engages in the manufacture of cell culture media and supplements. The company is headquartered in Hollister, California and currently employs 173 full-time employees. The company went IPO on 2021-06-25. The company offers two primary product categories, which include lab essentials and clinical solutions. The company also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The firm offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. The company supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.


What is the current price of TKNO stock?

The current stock price of TKNO is 3.8 USD. The price decreased by -0.26% in the last trading session.


Does TKNO stock pay dividends?

TKNO does not pay a dividend.


How is the ChartMill rating for ALPHA TEKNOVA INC?

TKNO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


How is the valuation of ALPHA TEKNOVA INC (TKNO) based on its PE ratio?

ALPHA TEKNOVA INC (TKNO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.35).


What is the expected growth for TKNO stock?

The Revenue of ALPHA TEKNOVA INC (TKNO) is expected to grow by 8.18% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


When does ALPHA TEKNOVA INC (TKNO) report earnings?

ALPHA TEKNOVA INC (TKNO) will report earnings on 2026-02-25, after the market close.


TKNO Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

TKNO Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to TKNO. The financial health of TKNO is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TKNO Financial Highlights

Over the last trailing twelve months TKNO reported a non-GAAP Earnings per Share(EPS) of -0.35. The EPS increased by 49.28% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -16.93%
ROE -25.08%
Debt/Equity 0.18
Chartmill High Growth Momentum
EPS Q2Q%46.67%
Sales Q2Q%9.17%
EPS 1Y (TTM)49.28%
Revenue 1Y (TTM)9.5%

TKNO Forecast & Estimates

12 analysts have analysed TKNO and the average price target is 9.18 USD. This implies a price increase of 141.58% is expected in the next year compared to the current price of 3.8.

For the next year, analysts expect an EPS growth of 42.95% and a revenue growth 8.18% for TKNO


Analysts
Analysts81.67
Price Target9.18 (141.58%)
EPS Next Y42.95%
Revenue Next Year8.18%

TKNO Ownership

Ownership
Inst Owners14%
Ins Owners10.67%
Short Float %17.58%
Short Ratio10.23